Daneng Li

30PUBLICATIONS
90CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapyPacific Peoples cultural determinants of healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

|Oct 30, 2025
LIF/LIFR Signaling in Gastric Cancer: A Double-Edged Sword in Tumor Progression and Therapeutic Resistance.

Daniel Park, Kyung-Il Kim, Yate-Ching Yuan

|Oct 18, 2024
Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial.

Teresa Macarulla, Zhenggang Ren, Hong Jae Chon

|Sep 14, 2024
Liver Resection for Gastroenteropancreatic Neuroendocrine Tumors with Extrahepatic Disease.

Kelly M Mahuron, Kristen E Limbach, Matthew C Hernandez

|Sep 12, 2024
Safety of pressurized intraperitoneal aerosolized chemotherapy in biliary cancer patients with peritoneal metastases.

Daneng Li, Christiana Crook, Vincent Chung

|Aug 04, 2024
The relationship of mental health symptoms to chemotherapy toxicity risk in older adults with cancer: Results from the geriatric assessment-driven intervention study.

Reena V Jayani, Anahid Hamparsumian, Canlan Sun

Pageof 5

Frequent Collaborators

8 joint publications

Christiana Joy Crook

4 joint publications

William Dale

3 joint publications

Mina S Sedrak

2 joint publications

Vincent Chung